Clinical trial
Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products
NCT00263809 · Terumo BCTbio, Industry · Completed
Key facts
| NCT number | NCT00263809 |
|---|---|
| Title | Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products |
| Official title | Evaluation of the Safety and Performance of Platelet Transfusion Products Treated With MIRASOL® Pathogen Reduction Technology. A Study in Human Thrombocytopenic Subjects. |
| Lead sponsor | Terumo BCTbio, Industry |
| Status | Completed |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Thrombocytopenia |
| Intervention type | Device |
| Interventions | Pathogen Reduction Technology |
| Enrollment | 118 |
| Start date | Dec 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Dec 9, 2005 |
| Last update posted | Oct 7, 2009 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: